Related Experiment Videos
Hepatobiliary scintigraphy in a pediatric population: determination of hepatic extraction fraction by deconvolution
R Howman-Giles1, A Moase, K Gaskin
1Department of Nuclear Medicine, Children's Hospital, Camperdown, Australia.
Insights
Measuring hepatic extraction fraction (HEF) and hepatic half clearance time (HCT) is feasible in pediatric patients with liver disease. Results showed significant variation, indicating potential for assessing liver function in children.
Area of Science:
- Pediatric Hepatology
- Liver Function Tests
- Clinical Measurement
Background:
- Assessing liver function in pediatric patients with hepatobiliary diseases is crucial.
- Hepatic extraction fraction (HEF) and hepatic half clearance time (HCT) are key functional parameters.
- Limited data exists on the feasibility of these measurements in pediatric populations.
Purpose of the Study:
- To evaluate the feasibility of measuring HEF and HCT in children with various hepatobiliary diseases.
- To compare HEF and HCT values between normal children and those with liver conditions.
- To determine if these parameters can differentiate between types of pediatric liver disease.
Main Methods:
- A study involving 45 pediatric patients categorized into normal, obstruction, hepatocellular disease (HCD), and miscellaneous groups.
- Measurement of hepatic extraction fraction (HEF) and hepatic half clearance time (HCT).
- Statistical comparison of HEF and HCT values across the different patient groups.
Main Results:
- Normal HEF averaged 99% +/- 3.6% and normal HCT was 23.6 +/- 7.7 min.
- Disease groups exhibited a wide range of HEF (15%-100%) and prolonged HCT (20-714 min).
- HEF in the HCD group was significantly lower than controls, but differentiation between disease groups was not possible due to overlap.
Conclusions:
- Measuring HEF and HCT is feasible and applicable in pediatric patients with hepatobiliary diseases.
- These functional parameters reflect varying degrees of liver dysfunction and cholestasis.
- While showing significant differences, HEF and HCT overlap limits their use in differentiating specific pediatric liver disease types.
Abstract:
A study was performed to assess the feasibility of measuring the hepatic extraction fraction (HEF) and hepatic half clearance time (HCT) in pediatric patients with a variety of hepatobiliary diseases. There were 45 children categorized into four groups: normal 12; obstruction 9; hepatocellular disease (HCD) 16 and miscellaneous 8. In the normal patients, the mean HEF was 99% +/- 3.6% and the HCT was 23.6 +/- 7.7 min. In the two disease categories, hepatocellular disease and obstruction, there was a wide range of HEF 15%-84% and 25%-100%, respectively. This reflected the varying degrees of liver dysfunction and/or cholestasis. The average results of HEF for the HCD group was significantly lower than controls, and the greatest difference of the HCD group and other disease groups was with the miscellaneous group. This was not, however, different from the obstructive group. There was, however, a large overlap of results, and differentiation between the disease groups was not possible. HCT from the disease groups also showed a prolonged average clearance when compared to normals, although this was not significant when the p value was adjusted for multiple comparisons. The normal HCT was 23.6 +/- 7.7 min, whereas the hepatobiliary disease groups ranged from 20 to 714 min. Again, there was considerable overlap of results in the disease groups. These functional parameters are feasible and applicable in the pediatric population.